Intellectual Property, net |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intellectual Property, net | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intellectual Property, net |
6. Intellectual Property, net
A continuity schedule for capitalized patents is presented below:
The Company evaluated its patent portfolio and determined that certain pending applications had been abandoned or will not be pursued. As such, during the nine-months ended May 31, 2024, the Company recognized an impairment loss of $57,836 related to those abandoned applications. The Company recognized $24,929 of amortization expense related to patents and licenses in the nine-months ended May 31, 2024. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for all or part of the information related to intangible assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|